These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7008998)

  • 1. Hypertrophic occlusive cardiomyopathy.
    Kaltenbach M; Hopf R
    Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
    [No Abstract]   [Full Text] [Related]  

  • 2. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
    Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
    Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
    Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
    Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
    [No Abstract]   [Full Text] [Related]  

  • 7. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy].
    Nowalany-Kozielska E; Wodniecki J; Tendera M; Poloński L
    Kardiol Pol; 1987; 30(7):409-18. PubMed ID: 3316787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
    Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
    Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular end-diastolic pressure-volume relationships in hypertrophic cardiomyopathy. Changes induced by verapamil.
    Tendera M; Polonski L; Kozielska E
    Chest; 1983 Jul; 84(1):54-7. PubMed ID: 6683147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
    Masini V; Ceci V; Malinconico U; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1729-37. PubMed ID: 7044864
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy: an overview.
    Epstein SE; Maron BJ
    Clin Invest Med; 1980; 3(1-2):185-93. PubMed ID: 7008999
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 17. [Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies].
    Gregor P; Widimský P; Cervenka V; Vísek V; Dvorák J; Sládková T
    Vnitr Lek; 1986 Dec; 32(12):1179-87. PubMed ID: 3824917
    [No Abstract]   [Full Text] [Related]  

  • 18. [Does verapamil affect the thickness of the cardiac muscle in hypertrophic cardiomyopathy?].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Vnitr Lek; 1986 Dec; 32(12):1188-96. PubMed ID: 3824918
    [No Abstract]   [Full Text] [Related]  

  • 19. Idiopathic hypertrophic subaortic stenosis.
    Arbogast RC; White RS
    Am Fam Physician; 1981 Jul; 24(1):97-101. PubMed ID: 7196144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of hypertrophic obstructive cardiomyopathy--usefulness of verapamil.
    Kober G; Schmidt-Moritz A; Hopf R; Kaltenbach M
    Eur Heart J; 1983 Nov; 4 Suppl F():165-74. PubMed ID: 6686532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.